Gold tier: mechanically validated evidence, with its primary source.
1,713 evidence items · page 7 / 69
218,600,000 inhabitantsBetween 2000 and 2010, the population in hyperendemic (>50% to 75% PfPR2-10) or holoendemic (>75% PfPR2-10) areas decreased from 218.6 million (34.4%) of 635.7 million to 183.5 million (22.5%) of 815.7 million across 44 malaria-endemic countries in Africa.
Kenyapaludismeobserved 2000published 2014Lancet (London, England)europe_pmcdocument of 4 observations
45.1 %Continuous monthly spatial repellent deployment with 100% coverage caused a 45.1% reduction in malaria infections versus no spatial repellent in western Kenya.
Kenyapaludismepublished 2026Epidemiology and infectionPubMeddocument of 4 observations
0.319 odds_ratioCarriage of HbSS was associated with reduced monocytosis in children with P. falciparum malaria in Kisumu County, Western Kenya.
Kenyadrépanocytose · paludismepublished 2020BMC infectious diseasesPubMeddocument of 8 observations
A Plasmodium falciparum malaria survey in school children was conducted across eight counties in western Kenya in 2019.
Kenyapaludismeobserved 2019published 2022Antimicrobial agents and chemotherapyeurope_pmcdocument of 5 observations
2.19 infections/person-yearThe cumulative incidence of malaria infections was 2.19 infections per person-year in the control arm.
Kenyapaludismepublished 2020The American journal of tropical medicine and hygienePubMeddocument of 2 observations
20.4 per_habitatThe high mean density of An. gambiae s.l. was 20.4 in farmland in Kakamega County, western Kenya between March and June 2019.
Kenyapaludismeobserved March and June 2019published 2021Ethiopian journal of health sciencesPubMeddocument of 8 observations
29 parasites/µLAmong afebrile women (n = 392), the geometric-mean parasite density was 29 parasites/µL.
Kenyapaludismepublished 2022The Journal of infectious diseasesPubMeddocument of 13 observations
7.8 %Parasite prevalence by qPCR was 7.8% in Homa Bay during the wet season.
Kenyapaludismeobserved wet seasonpublished 2021BMC infectious diseasesPubMeddocument of 10 observations
56 %46 (56%) first-febrile infections were polyclonal.
Kenyapaludismepublished 2022Malaria journalPubMeddocument of 8 observations
43 %Vaccine efficacy against all episodes of clinical malaria was 43% (95% CI 28-55) in the Fx012-14-26-38 group up to month 50.
Kenyapaludismepublished 2025The Lancet. Global healthPubMeddocument of 9 observations
90 %Compliance with no anti-malarial treatment for test-negative patients ranged from 90% to 92% across surveys conducted between 2014 and 2016 in Kenya.
Kenyapaludismeobserved 2014–2016published 2022Malaria journaleurope_pmcdocument of 5 observations
4 %The C469Y mutation declined from 4% in 2022 to 1% in 2023.
Kenyapaludismeobserved 2022published 2025Scientific reportsPubMeddocument of 6 observations
85 %Malaria testing services were available at more than 85% of facilities.
Kenyapaludismepublished 2022Malaria journaleurope_pmcdocument of 10 observationsDOI 10.1186/s12936-022-04048-2
230,174 individualsPlasmodium falciparum prevalence data covered an examination of 230,174 individuals located in northern Namibia.
Kenyapaludismeobserved 1969–1992published 2013PloS oneeurope_pmcdocument of 6 observations
5.4 per_1000The mean incidence of Plasmodium vivax in 2009 was 5.4 cases per 1000 population.
Kenyapaludismeobserved 2009published 2014PloS oneeurope_pmcdocument of 7 observations
The introduction of insecticide-treated bed nets during a randomized controlled trial on the Kenyan coast significantly reduced severe, life-threatening malaria and all-cause childhood mortality.
Kenyapaludismepublished 1997Acta tropicaeurope_pmcdocument of 4 observations
8 %National malaria prevalence in Kenya was 8% in 2018.
Kenyapaludismeobserved 2018published 2022Malaria journalPubMeddocument of 8 observations
3 foldMalaria prevalence is three-fold higher in western Kenya than the national average of 6%.
Kenyapaludismepublished 2023Malaria journalPubMeddocument of 8 observations
0.03 USDIf implemented nationally, the cost per additional child correctly managed was estimated at 0.03 USD.
Kenyapaludismeobserved 2010published 2012PloS oneeurope_pmcdocument of 5 observations
The prevalence of sporozoite antibodies varied with age among children aged one to nine years resident in a rural area of The Gambia.
Kenyapaludismepublished 1989Annals of tropical medicine and parasitologyeurope_pmcdocument of 4 observations
29 %29% of children aged 3-59 months experienced fever within 2 weeks before the interview.
Kenyapaludismepublished 2011PLoS medicineeurope_pmcdocument of 3 observationsDOI 10.1371/journal.pmed.1000437
0.82 utility_scoreFor uncomplicated malaria, the median utility score was 0.82 using the Ethiopian value set.
Kenyapaludismeobserved June to September 2024published 2025Health and quality of life outcomeseurope_pmcdocument of 8 observations
A single isolate from Western Kenya contained the PfK13 V568I variant, potentially linked to reduced susceptibility to artemisinin.
Kenyapaludismepublished 2024Scientific reportsPubMeddocument of 3 observations
0.7 incidence_rate_ratioIn an interim analysis of the EPI-MAL-003 study, the country-adjusted incidence rate ratio for any malaria among vaccinated children from exposed clusters compared to unvaccinated children from unexposed clusters was 0.70.
Kenyapaludismepublished 2026The Lancet. Global healthPubMeddocument of 10 observations
83.6 %In 2018, 83.6% of Plasmodium falciparum parasites in Kilifi county, Kenya carried the quintuple mutation form of sulfadoxine-pyrimethamine resistance.
Kenyapaludismeobserved 2018published 2022Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodiumeurope_pmcdocument of 5 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.